Surgery Partners Inc (NASDAQ: SGRY) stock fell -0.40% on Monday to $32.11 against a previous-day closing price of $32.24. With 0.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.83 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $32.76 whereas the lowest price it dropped to was $31.89. The 52-week range on SGRY shows that it touched its highest point at $45.79 and its lowest point at $22.05 during that stretch. It currently has a 1-year price target of $43.20. Beta for the stock currently stands at 2.85.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SGRY was up-trending over the past week, with a rise of 20.26%, but this was up by 30.63% over a month. Three-month performance dropped to -4.83% while six-month performance fell -15.94%. The stock gained 18.84% in the past year, while it has gained 15.25% so far this year. A look at the trailing 12-month EPS for SGRY yields -0.32 with Next year EPS estimates of 0.96. For the next quarter, that number is 0.38. This implies an EPS growth rate of 479.51% for this year and 3.74% for next year. EPS is expected to grow by 75.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 18.22%.
Float and Shares Shorts:
At present, 125.96 million SGRY shares are outstanding with a float of 65.22 million shares on hand for trading. On Oct 30, 2023, short shares totaled 7.45 million, which was 5.89% higher than short shares on Sep 28, 2023. In addition to Mr. Wayne Scott DeVeydt as the firm’s Executive Chairman, Mr. J. Eric Evans serves as its CEO & Director.
Through their ownership of 103.62% of SGRY’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 84.91% of SGRY, in contrast to 41.52% held by mutual funds. Shares owned by individuals account for 18.04%. As the largest shareholder in SGRY with 13.38% of the stake, Fidelity Management & Research Co holds 16,929,454 shares worth 16,929,454. A second-largest stockholder of SGRY, Wellington Management Co. LLP, holds 8,022,700 shares, controlling over 6.34% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in SGRY, holding 6,528,051 shares or 5.16% stake. With a 3.08% stake in SGRY, the Fidelity Select Port. – Health Ca is the largest stakeholder. A total of 3,900,000 shares are owned by the mutual fund manager. The Fidelity Balanced Fund, which owns about 2.34% of SGRY stock, is the second-largest Mutual Fund holder. It holds 2,959,154 shares valued at 68.45 million. ClearBridge Small Cap Growth Fund holds 2.18% of the stake in SGRY, owning 2,762,807 shares worth 63.9 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SGRY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SGRY analysts setting a high price target of $50.00 and a low target of $35.00, the average target price over the next 12 months is $43.20. Based on these targets, SGRY could surge 55.71% to reach the target high and rise by 9.0% to reach the target low. Reaching the average price target will result in a growth of 34.54% from current levels.
Summary of Insider Activity:
Insiders traded SGRY stock several times over the past three months with 0 Buys and 3 Sells. In these transactions, 0 shares were bought while 6,037 shares were sold. The number of buy transactions has increased to 20 while that of sell transactions has risen to 40 over the past year. The total number of shares bought during that period was 27,858,420 while 159,212 shares were sold.